
|Articles|January 7, 2020
Signant Health Partners with Propeller Health
Advertisement
Signant Health has announced a partnership to connect TrialMax to Propeller Health’s digital health platform for asthma and chronic obstructive pulmonary disease. The partnership will help drive patient adherence to inhaled medications by enabling accurate time tracking of patients’ medication use events alongside their eDiary data within a single electronic Clinical Outcome Assessment platform.
To learn more, click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Approves Oral Wegovy Following Positive Phase III OASIS 4 Trial Results
2
Our Top 5 Most Read Articles in 2025
3
ACT Brief: FDA Approval of Oral Wegovy, 2025’s Most-Read ACT Coverage, and Data Quality as the Foundation for AI
4
ACT Brief: AI-Enabled Workflow Automation, Subcutaneous Lunsumio VELO Approval, and Pan-KRAS Early-Stage Development
5




